Novel modes of action of emerging therapies could enhance strategies to combat drug-resistant HIV.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Opar, A. New HIV drug classes on the horizon. Nat Rev Drug Discov 6, 258–259 (2007). https://doi.org/10.1038/nrd2294
Issue Date:
DOI: https://doi.org/10.1038/nrd2294
This article is cited by
-
QSAR modeling of the inhibition of reverse transcriptase enzyme with benzimidazolone analogs
Medicinal Chemistry Research (2011)
-
Bioinformatics prediction of HIV coreceptor usage
Nature Biotechnology (2007)
-
News Analysis
Nature Reviews Drug Discovery (2007)